| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |